361 related articles for article (PubMed ID: 7452496)
1. The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol.
Buckpitt AR; Boyd MR
J Pharmacol Exp Ther; 1980 Oct; 215(1):97-103. PubMed ID: 7452496
[TBL] [Abstract][Full Text] [Related]
2. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
Buckpitt AR; Bahnson LS; Franklin RB
J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
[TBL] [Abstract][Full Text] [Related]
3. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse.
Boyd MR; Dutcher JS
J Pharmacol Exp Ther; 1981 Mar; 216(3):640-6. PubMed ID: 7205642
[TBL] [Abstract][Full Text] [Related]
4. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo.
Buckpitt AR; Warren DL
J Pharmacol Exp Ther; 1983 Apr; 225(1):8-16. PubMed ID: 6834280
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies on the metabolic activation of the pulmonary toxin, 4-ipomeanol, by rat lung and liver microsomes.
Boyd MR; Burka LT; Wilson BJ; Sasame HA
J Pharmacol Exp Ther; 1978 Dec; 207(3):677-86. PubMed ID: 32381
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
Wolf CR; Statham CN; McMenamin MG; Bend JR; Boyd MR; Philpot RM
Mol Pharmacol; 1982 Nov; 22(3):738-44. PubMed ID: 7155130
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ratios of covalent binding to total metabolism of the pulmonary toxin, 4-ipomeanol, in vitro in pulmonary and hepatic microsomes, and the effects of pretreatments with phenobarbital or 3-methylcholanthrene.
Boyd MR; Sasame HA; Franklin RB
Biochem Biophys Res Commun; 1980 Apr; 93(4):1167-72. PubMed ID: 7396903
[No Abstract] [Full Text] [Related]
8. Detection of glutathione conjugates derived from 4-ipomeanol metabolism in bile of rats by liquid chromatography-tandem mass spectrometry.
Alvarez-Diez TM; Zheng J
Drug Metab Dispos; 2004 Dec; 32(12):1345-50. PubMed ID: 15328249
[TBL] [Abstract][Full Text] [Related]
9. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system.
Slaughter SR; Statham CN; Philpot RM; Boyd MR
J Pharmacol Exp Ther; 1983 Jan; 224(1):252-7. PubMed ID: 6848746
[TBL] [Abstract][Full Text] [Related]
10. Formation of glutathione conjugates by reactive metabolites of vinylidene chloride in microsomes and isolated hepatocytes.
Liebler DC; Meredith MJ; Guengerich FP
Cancer Res; 1985 Jan; 45(1):186-93. PubMed ID: 3965130
[TBL] [Abstract][Full Text] [Related]
11. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
Juedes MJ; Bulger WH; Kupfer D
Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703
[TBL] [Abstract][Full Text] [Related]
12. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolic conversion of aflatoxins and benzo(alpha)pyrene to nucleic acid-binding metabolites.
Gurtoo HL; Dave CV
Cancer Res; 1975 Feb; 35(2):382-9. PubMed ID: 234034
[TBL] [Abstract][Full Text] [Related]
14. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
[TBL] [Abstract][Full Text] [Related]
15. Stereoselectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic, and renal microsomal enzymes.
Buckpitt AR; Castagnoli N; Nelson SD; Jones AD; Bahnson LS
Drug Metab Dispos; 1987; 15(4):491-8. PubMed ID: 2888622
[TBL] [Abstract][Full Text] [Related]
16. Formation of nontoxic reactive metabolites of p-bromophenol. Identification of a new glutathione conjugate.
Monks TJ; Lau SS; Highet RJ
Drug Metab Dispos; 1984; 12(4):432-7. PubMed ID: 6148209
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolic activation of the pulmonary toxin, 4-ipomeanol, in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lung.
Devereux TR; Jones KG; Bend JR; Fouts JR; Statham CN; Boyd MR
J Pharmacol Exp Ther; 1982 Jan; 220(1):223-7. PubMed ID: 7053419
[TBL] [Abstract][Full Text] [Related]
18. Microsomal metabolism and covalent binding of [3H/14C]-bromobenzene. Evidence for quinones as reactive metabolites.
Narasimhan N; Weller PE; Buben JA; Wiley RA; Hanzlik RP
Xenobiotica; 1988 May; 18(5):491-9. PubMed ID: 3400271
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 3-tert-butyl-4-hydroxyanisole by microsomal fractions and isolated rat hepatocytes.
Cummings SW; Ansari GA; Guengerich FP; Crouch LS; Prough RA
Cancer Res; 1985 Nov; 45(11 Pt 2):5617-24. PubMed ID: 4053035
[TBL] [Abstract][Full Text] [Related]
20. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol.
Boyd MR; Burka LT
J Pharmacol Exp Ther; 1978 Dec; 207(3):687-97. PubMed ID: 731424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
